home / stock / alec / alec news

ALEC News and Press, Alector Inc.

Stock Information
Company Name: Alector Inc.
Stock Symbol: ALEC
Market: NYSE
Website: alector.com
Menu
ALEC ALEC Quote ALEC Short ALEC News ALEC Articles ALEC Message Board
Get ALEC Alerts

News, Short Squeeze, Breakout and More Instantly...
ALEC - Alector: Brain Science Play With High Expenses And Few Catalysts

2024-07-12 16:48:36 ET Summary Alector's lead pipeline assets are for challenging brain disorders. Ample liquidity assures that Alector can develop its lead assets over the near term. Its lead pipeline candidates generate milestone revenues. With a high expense profile and...
ALEC - Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...

ALEC - Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB...

ALEC - Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Co...
ALEC - The Limitations Of Anti-Inflammatory Drugs For The Treatment Of Alzheimer's Disease

2024-05-19 01:10:48 ET Summary Anti-inflammatory drugs are likely to have limited effects on Alzheimer's disease because they are not stopping early oxidation and nitration. Neuroinflammation in Alzheimer's disease is primarily caused by oxidative and nitrosative stress. Inhib...

ALEC - Alector GAAP EPS of -$0.38 beats by $0.16, revenue of $15.89M beats by $0.13M

2024-05-08 17:46:02 ET More on Alector Alector, Inc. (ALEC) Q4 2023 Earnings Call Transcript Alector GAAP EPS of -$0.49 beats by $0.28, revenue of $15.2M beats by $6.36M Seeking Alpha’s Quant Rating on Alector Historical earnings data for Alector ...

ALEC - Alector Reports First Quarter 2024 Financial Results and Provides Business Update

Data from INVOKE-2, evaluating the most advanced TREM2 candidate in clinical development for early Alzheimer’s disease, on track for Q4 2024 Strengthened leadership team with key appointments: Neil Berkley, M.S., M.B.A., named Chief Business Officer; Errol De Souza, Ph.D....
ALEC - Expected US Company Earnings on Thursday, May 2nd, 2024

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

ALEC - (ALEC) Technical Data

2024-04-16 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ALEC - Trend Tracker for (ALEC)

2024-03-18 01:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Next 10